The Adjuvant Chemotherapy Trial of TS-1 for Colon Cancer (ACTS-CC) is a phase III trial designed to validate the non-inferiority of S-1 to UFT/leucovorin (LV) as postoperative adjuvant chemotherapy ...

The white paper from Micro Focus describes UFT One as, “QA and testing teams can efficiently scale tests across distributed infrastructures and in parallel on web and mobile; script once and replay ...